Alcon Ag (ALC)

$93.37

+1.53

(+1.67%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $93.04
    $94.20
    $93.37
    downward going graph

    0.35%

    Downside

    Day's Volatility :1.23%

    Upside

    0.88%

    downward going graph
  • $69.21
    $93.39
    $93.37
    downward going graph

    25.88%

    Downside

    52 Weeks Volatility :25.89%

    Upside

    0.02%

    downward going graph

Returns

PeriodAlcon AgSector (Health Care)Index (Russel 2000)
3 Months
16.59%
6.5%
0.0%
6 Months
20.84%
7.1%
0.0%
1 Year
8.21%
9.8%
0.0%
3 Years
30.7%
14.2%
-20.2%

Highlights

Market Capitalization
45.8B
Book Value
$42.13
Dividend Share
0.285
Dividend Yield
0.29%
Earnings Per Share (EPS)
2.11
PE Ratio
44.05
PEG Ratio
4.59
Wall Street Target Price
96.14
Profit Margin
10.96%
Operating Margin TTM
15.09%
Return On Assets TTM
2.38%
Return On Equity TTM
5.15%
Revenue TTM
9.6B
Revenue Per Share TTM
19.38
Quarterly Revenue Growth YOY
4.5%
Gross Profit TTM
4.8B
EBITDA
2.2B
Diluted Eps TTM
2.11
Quarterly Earnings Growth YOY
0.43
EPS Estimate Current Year
3.07
EPS Estimate Next Year
3.51
EPS Estimate Current Quarter
0.73
EPS Estimate Next Quarter
0.75

Analyst Recommendation

Buy
    82%Buy
    13%Hold
    4%Sell
Based on 23 Wall street analysts offering stock ratings for Alcon Ag(by analysts ranked 0 to 5 stars)
Based on 23 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
18
Hold
3
3
4
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 2.97%

Current $93.37
Target $96.14

Company Financials

FY18Y/Y Change
Revenue
7.2B
↑ 5.32%
Net Income
-227.0M
↓ 188.67%
Net Profit Margin
-3.17%
↓ 6.94%
FY19Y/Y Change
Revenue
7.5B
↑ 4.96%
Net Income
-656.0M
↑ 188.99%
Net Profit Margin
-8.74%
↓ 5.57%
FY20Y/Y Change
Revenue
6.8B
↓ 8.99%
Net Income
-531.0M
↓ 19.05%
Net Profit Margin
-7.77%
↑ 0.97%
FY21Y/Y Change
Revenue
8.3B
↑ 21.34%
Net Income
376.0M
↓ 170.81%
Net Profit Margin
4.54%
↑ 12.31%
FY22Y/Y Change
Revenue
8.7B
↑ 5.14%
Net Income
335.0M
↓ 10.9%
Net Profit Margin
3.84%
↓ 0.7%
FY23Y/Y Change
Revenue
10.1B
↑ 15.77%
Net Income
974.0M
↑ 190.75%
Net Profit Margin
9.65%
↑ 5.81%
Q4 FY22Q/Q Change
Revenue
2.2B
↑ 1.45%
Net Income
-97.0M
↓ 183.62%
Net Profit Margin
-4.47%
↓ 9.89%
Q1 FY23Q/Q Change
Revenue
2.4B
↑ 8.34%
Net Income
174.0M
↓ 279.38%
Net Profit Margin
7.4%
↑ 11.87%
Q2 FY23Q/Q Change
Revenue
2.4B
↑ 2.98%
Net Income
169.0M
↓ 2.87%
Net Profit Margin
6.98%
↓ 0.42%
Q3 FY23Q/Q Change
Revenue
2.3B
↓ 3.84%
Net Income
204.0M
↑ 20.71%
Net Profit Margin
8.76%
↑ 1.78%
Q4 FY23Q/Q Change
Revenue
2.5B
↑ 6.42%
Net Income
427.0M
↑ 109.31%
Net Profit Margin
17.23%
↑ 8.47%
Q1 FY24Q/Q Change
Revenue
2.5B
↓ 0.79%
Net Income
248.0M
↓ 41.92%
Net Profit Margin
10.09%
↓ 7.14%
FY18Y/Y Change
Total Assets
27.1B
↓ 1.19%
Total Liabilities
4.4B
↑ 1.47%
FY19Y/Y Change
Total Assets
27.7B
↑ 2.19%
Total Liabilities
8.4B
↑ 88.83%
FY20Y/Y Change
Total Assets
27.6B
↓ 0.2%
Total Liabilities
8.8B
↑ 5.1%
FY21Y/Y Change
Total Assets
28.0B
↑ 1.45%
Total Liabilities
8.7B
↓ 0.4%
FY22Y/Y Change
Total Assets
29.2B
↑ 4.32%
Total Liabilities
9.5B
↑ 9.02%
FY23Y/Y Change
Total Assets
29.6B
↑ 1.35%
Total Liabilities
9.0B
↓ 5.72%
Q4 FY22Q/Q Change
Total Assets
29.2B
↑ 5.08%
Total Liabilities
9.5B
↑ 16.97%
Q1 FY23Q/Q Change
Total Assets
29.2B
↑ 0.07%
Total Liabilities
9.4B
↓ 1.31%
Q2 FY23Q/Q Change
Total Assets
29.2B
↓ 0.16%
Total Liabilities
9.3B
↓ 1.55%
Q3 FY23Q/Q Change
Total Assets
29.3B
↑ 0.57%
Total Liabilities
9.2B
↓ 0.55%
Q4 FY23Q/Q Change
Total Assets
29.6B
↑ 0.88%
Total Liabilities
9.0B
↓ 2.42%
Q1 FY24Q/Q Change
Total Assets
29.6B
↓ 0.13%
Total Liabilities
8.7B
↓ 2.77%
FY18Y/Y Change
Operating Cash Flow
1.1B
↓ 6.4%
Investing Cash Flow
-1.0B
↑ 47.42%
Financing Cash Flow
-78.0M
↓ 85.53%
FY19Y/Y Change
Operating Cash Flow
920.0M
↓ 19.3%
Investing Cash Flow
-1.0B
↑ 1.0%
Financing Cash Flow
659.0M
↓ 944.87%
FY20Y/Y Change
Operating Cash Flow
823.0M
↓ 10.54%
Investing Cash Flow
-572.0M
↓ 43.42%
Financing Cash Flow
466.0M
↓ 29.29%
FY21Y/Y Change
Operating Cash Flow
1.3B
↑ 63.43%
Investing Cash Flow
-1.2B
↑ 109.44%
Financing Cash Flow
-123.0M
↓ 126.39%
FY22Y/Y Change
Operating Cash Flow
1.2B
↓ 9.52%
Investing Cash Flow
-1.9B
↑ 55.68%
Financing Cash Flow
-8.0M
↓ 93.5%
Q4 FY22Q/Q Change
Operating Cash Flow
345.0M
↓ 14.18%
Investing Cash Flow
-852.0M
↑ 239.44%
Financing Cash Flow
281.0M
↓ 2441.67%
Q1 FY23Q/Q Change
Operating Cash Flow
85.9M
↓ 75.1%
Investing Cash Flow
-413.0M
↓ 51.53%
Financing Cash Flow
-21.2M
↓ 107.55%
Q2 FY23Q/Q Change
Operating Cash Flow
325.0M
↑ 278.33%
Investing Cash Flow
-413.0M
↑ 0.0%
Financing Cash Flow
-145.0M
↑ 583.22%
Q3 FY23Q/Q Change
Operating Cash Flow
501.7M
↑ 54.37%
Investing Cash Flow
-152.0M
↓ 63.2%
Financing Cash Flow
12.4M
↓ 108.58%

Technicals Summary

Sell

Neutral

Buy

Alcon Ag is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alcon Ag
Alcon Ag
2.41%
20.84%
8.21%
30.7%
54.72%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-1.32%
16.54%
32.6%
35.62%
148.32%
Resmed Inc.
Resmed Inc.
11.69%
9.57%
-6.0%
-19.79%
64.22%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.5%
-1.64%
-17.69%
-6.68%
-8.49%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-14.37%
-23.3%
-26.95%
-26.58%
102.44%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alcon Ag
Alcon Ag
44.05
44.05
4.59
3.07
0.05
0.02
0.0
42.13
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
78.14
78.14
7.13
6.63
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
32.24
32.24
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
50.71
50.71
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
6.72
7.74
0.21
0.11
0.0
36.72
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alcon Ag
Alcon Ag
Buy
$45.8B
54.72%
44.05
10.96%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$161.3B
148.32%
78.14
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
64.22%
32.24
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$68.6B
-8.49%
50.71
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.7B
102.44%
42.71
19.42%

Insights on Alcon Ag

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 2.47B → 2.45B (in $), with an average decrease of 0.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 427.0M → 248.0M (in $), with an average decrease of 41.9% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 32.6% return, outperforming this stock by 24.4%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 35.6% return, outperforming this stock by 4.9%

Institutional Holdings

  • Aristotle Capital Management LLC

    2.46%

  • Harding Loevner L.P.

    1.70%

  • Ako Capital Llp

    1.32%

  • T. Rowe Price Investment Management,Inc.

    1.30%

  • Bank of New York Mellon Corp

    1.15%

  • FMR Inc

    1.13%

Corporate Announcements

  • Alcon Ag Dividends September,2024

    In the quarter ending September,2024. Alcon Ag has declared dividend of $0.24

    Read More

Company Information

Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.

Organization
Alcon Ag
Employees
25000
CEO
Mr. F. Michael Ball
Industry
Electronic Equipment/Instruments

Discover More

FAQs